Skip to main content
logo
Hubei Goto Biopharm Group Co., Ltd. (SHE:300966)
China flag China · Delayed Price · Currency is CNY
26.60
+0.68 (2.62%)
Sep 23, 2026, 3:04 PM CST

Hubei Goto Biopharm Group Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
650.05606.18536.6566.4604.57590.89
Revenue Growth
7.42%12.97%-5.26%-6.31%2.32%26.23%
Gross Profit
63.4272.69100.89116.11137.81144.26
Operating Income
-63.05-54.25-14.7326.9345.4664.48
Net Income
-95.05-73.36-27.5923.0140.2178.33
Earnings Per Share
-0.82-0.64-0.240.200.350.74
EPS Growth
----42.86%-52.81%19.63%

Revenue by Segment
Chart
Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Self-Produced
548.18427.81394.89441.8472.41
Non-Self Produced
58108.79171.51162.77118.48
Total
606.18536.6566.4604.57590.89

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
76.0685.85141.18181.97453.43210.02
Total Debt
1,3221,2991,132785.73770.3161.54
Net Cash (Debt)
-1,246-1,213-990.37-603.75-316.8748.47
Net Cash Growth
------
Net Cash Per Share
-10.79-10.59-8.61-5.25-2.760.46

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
69.3141.04-20.5968.13-24.0458
Capital Expenditures
-86.16-166.33-311.61-409.25-407.94-90.91
Free Cash Flow
-16.85-125.29-332.2-341.12-431.98-32.91
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
9.76%11.99%18.80%20.50%22.79%24.41%
Operating Margin
-9.70%-8.95%-2.74%4.75%7.52%10.91%
Pretax Margin
-18.50%-17.36%-8.49%3.38%6.37%14.57%
Profit Margin
-14.62%-12.10%-5.14%4.06%6.65%13.26%
FCF Margin
-2.59%-20.67%-61.91%-60.23%-71.45%-5.57%

Dividends
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.0450.045-0.016-0.136
Dividend Per Share Growth
0%-----
Dividend Yield
0.17%0.23%-0.07%-0.33%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
---115.1077.4260.37
PS Ratio
4.673.743.474.685.158.00